Correction: Respiratory infection‑ and asthma‑prone, low vaccine responder children demonstrate distinct mononuclear cell DNA methylation pathways
David Martino, Nikki Schultz, Ravinder Kaur, Simon D. van Haren, Nina Kresoje, Annmarie Hoch, Joann Diray‑Arce, Jessica Lasky Su, Ofer Levy, Michael Pichichero
Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsVaccine Coverage and Hesitancy · Immune responses and vaccinations
Correction to: Clinical Epigenetics (2024) 16:85 10.1186/s13148-024-01703-0
The original publication of this article [1] contained an error in the demographic data of Table 1. The incidence of strictly defined otitis media prone (SOP) among cases (infection prone children) and controls (non-infection prone) was incorrectly stated. The published table shows cases of SOP in 10 infection prone children and 0 in non-infection prone but they should have been 11 and 1, respectively.
The incorrect and correct Table 1 have shown with this correction article.
Incorrect Table 1:
Table 1. Demographics of study cohortVariableCategoryIAPNIAPOverallP-valueVaccine responsiveness0.019High vaccine response(1) 7%(5) 31%(6) 20%Normal vaccine response(6) 43%(10) 62%(16) 53%Low vaccine response(7) 50%(1) 6%(8) 26%Otitis prone status < 0.001Stringently defined otitis prone(10) 71%(0) 0%(10) 33%Non otitis prone(4) 29%(16) 100%(20) 67%Atopy0.675Eczema(4) 29%(3) 18%(7) 23%Sex0.44Female(3) 21%(6) 38%(9) 30%Male(11) 79%(10) 62%(21) 70%Age (months)Mean9.9 ± 210.76 ± 1.5910.36 ± 1.810.211Ancestry0.485African American(0) 0%(1) 6%(1) 3%Caucasian(14) 100%(13) 81%(27) 90%Other(0) 0%(2) 12%(2) 7%Daycare0.142Yes(11) 79%(8) 50%(19) 63%No(3) 21%(8) 50%(11) 37%Breastfeeding0.883Breastfed(4) 29%(3) 19%(7) 23%Formula fed(8) 57%(10) 62%(18) 60%Both(2) 14%(3) 19%(5) 17%Smokers in home1.00Yes(0) 0%(1) 6%(1) 3%No(14) 100%(15) 94%(29) 97%Siblings0.457Yes(7) 50%(11) 69%(18) 60%No(7) 50%(5) 31%(12) 40%P-values are determined using Fishers Exact for categorical variables and t-test for quantitative variables
Correct Table 1:
Table 1. Demographics of study cohortVariableCategoryIAPNIAPOverallP-valueVaccine responsiveness0.019High vaccine response(1) 7%(5) 31%(6) 20%Normal vaccine response(6) 43%(10) 62%(16) 53%Low vaccine response(7) 50%(1) 6%(8) 26%Otitis prone status < 0.001Stringently defined otitis prone(11) 79%(1) 6%(12) 40%Non otitis prone(3) 21%(15) 94%(18) 60%Atopy0.675Eczema(4) 29%(3) 18%(7) 23%Sex0.44Female(3) 21%(6) 38%(9) 30%Male(11) 79%(10) 62%(21) 70%Age (months)Mean9.9 ± 210.76 ± 1.5910.36 ± 1.810.211Ancestry0.485African American(0) 0%(1) 6%(1) 3%Caucasian(14) 100%(13) 81%(27) 90%Other(0) 0%(2) 12%(2) 7%Daycare0.142Yes(11) 79%(8) 50%(19) 63%No(3) 21%(8) 50%(11) 37%Breastfeeding0.883Breastfed(4) 29%(3) 19%(7) 23%Formula fed(8) 57%(10) 62%(18) 60%Both(2) 14%(3) 19%(5) 17%Smokers in home1.00Yes(0) 0%(1) 6%(1) 3%No(14) 100%(15) 94%(29) 97%Siblings0.457Yes(7) 50%(11) 69%(18) 60%No(7) 50%(5) 31%(12) 40%P-values are determined using Fishers Exact for categorical variables and t-test for quantitative variables